Cancer is a global health issue, which affects all of us directly or indirectly in the course of our lifetimes. The Swiss Cancer Research foundation, a patient-oriented non-profit organization, supports high-quality research projects to fuel the progress of new and evolving immune-based therapies that hold more potential in fighting cancer than current treatment approaches.
In 2013, 8.2 million patients died of cancer and about 196.3 million healthy life years were lost worldwide. Immunotherapy represents the most promising new cancer treatment approach since the introduction of chemotherapy in the 1960s and uses the patient's immune system to detect, attack and combat cancer cells. This therapy is emerging as THE new weapon in the battle against this deadly disease, but more research is highly needed so that more patients can benefit from it.
To continue to advance treatment options for cancer patients, funding for research is needed. Donate to the Swiss Cancer Research foundation to help continue to find answers. Swiss cancer research centres are among the world's best institutes for biomedical and clinical research. Cancer patients worldwide will benefit from your contribution and this expertise.
Immunotherapy offers prevention from cancer. It may not only have the potential to efficiently and sustainably attack tumors and metastases, but also prevent cancer development. International networking allows cancer patients around the world to benefit from this new therapeutic approach, and the more research is done, the closer we are to effective treatments. Thank you for making a meaningful difference in the lives of patients with cancer.